<![CDATA[Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts]]>
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing G...
More than 15 proprietary brands and product lines, plus 10 branded generics - across nutraceuticals, infection control, advanced formulations, skin care and mother & baby, and...
The Importance of Software Development for the Pharmaceutical Market!
An increased level of competition characterizes the pharmaceutical market. Therefore, it is almost impossible to stay on it without marketing knowledge. Marketing as a philosophy o...
<![CDATA[Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million]]>
The Biggest Pharmaceutical Launches in History—and What They Teach Us About Winning in Today’s Market
The Biggest Pharmaceutical Launches in History—and What They Teach Us About Winning in Today’s Market Anonymous (not verified) Wed, 10/21/2026 - 22:16 pharmagather item...
<![CDATA[ The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals]]>
<![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]>
<![CDATA[The Therapeutic Areas or Deals That Might Be Negatively Impacted by MFN Deals]]>
<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>
Pills are paying off now! Pharma stocks drive 2026 rally with up to 112% returns
In 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic demand alongside enhanced profitability from...
<![CDATA[ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million]]&...
<![CDATA[A Steadying Trajectory: Biopharma Review and Outlook]]>
GLOBE and MFN Pricing: Implications for Cross-Border Drug Development and Transactions
On Oct. 2, 2026, the Centers for Medicare & Medicaid Services (CMS) published the final rule for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. GLOBE is a manda...
<![CDATA[Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somniver...
<![CDATA[Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche ]]>
<![CDATA[M&A Roundup: Johnson & Johnson Acquires Ollin Biosciences, Eli Lilly Acquires Calytrix Bio, AmyriAD...
4 largest PBMs control 75% of U.S. market, AMA finds
The four largest PBMs by national market share were OptumRx (23%), Express Scripts (23%), CVS/Caremark (18%) and Prime Therapeutics (11%).
<![CDATA[Where Most Pharma Companies Still Have Meaningful Gaps in Their Supply Chains: LogiPharma 2026]]>
<![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>
<![CDATA[Novartis Trims Growth Target at Annual Management Day, Shares Slide]]>
<![CDATA[Single Partner Platforms: Enhancing the Prescription Journey for Manufacturers]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.